UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029714
Receipt number R000033956
Scientific Title Analysis of the relationship between rheological parameters and sensory evaluation of heparin-containing preparations
Date of disclosure of the study information 2017/11/01
Last modified on 2019/10/29 11:05:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the relationship between rheological parameters and sensory evaluation of heparin-containing preparations

Acronym

Analysis of the relationship between rheological parameters and sensory evaluation of heparin-containing preparations

Scientific Title

Analysis of the relationship between rheological parameters and sensory evaluation of heparin-containing preparations

Scientific Title:Acronym

Analysis of the relationship between rheological parameters and sensory evaluation of heparin-containing preparations

Region

Japan


Condition

Condition

Normal

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the usability required for topical external pharmaceutical formulations containing heparin analogues

Basic objectives2

Others

Basic objectives -Others

Scientific basis for selecting dosage forms based on usability such as physiological and sensory characteristics

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Sensory evaluation on usability

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Medicine

Interventions/Control_1

Apply approximately 250 mg to normal skin once to give a circle with a diameter of about 5 cm (area 19.5 cm^2).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1.Be able to acquire consent in writing by the principal concerning participation in the exam.
2.Regardless of age and sex.
3.Before starting the study, you should not receive external medication containing heparin analogue.

Key exclusion criteria

1.Hemorrhagic hematologic disorder (haemophilia, thrombocytopenia, purpura etc) must be present.
2.It is expected that even a slight bleeding will have serious consequences.
3.Person who has a history of hypersensitivity to heparin analogue.
4.A woman who may be pregnant.
5.Person who are applying steroid drugs.
6.Person who have judged that the research director is inappropriate as the object of this examination.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Toyofumi
Middle name
Last name Suzuki

Organization

Nihon University, School of Pharmacy

Division name

Laboratory of Pharmaceutics

Zip code

2748555

Address

7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan

TEL

0474655877

Email

suzuki.toyofumi@nihon-u.ac.jp


Public contact

Name of contact person

1st name Toyofumi
Middle name
Last name Suzuki

Organization

Nihon University, School of Pharmacy

Division name

Laboratory of Pharmaceutics

Zip code

2748555

Address

7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan

TEL

0474655877

Homepage URL


Email

suzuki.toyofumi@nihon-u.ac.jp


Sponsor or person

Institute

Laboratory of Pharmaceutics, Nihon University, School of Pharmacy

Institute

Department

Personal name



Funding Source

Organization

Laboratory of Pharmaceutics, Nihon University, School of Pharmacy

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

School of Pharmacy, Nihon University

Address

7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan

Tel

0474655877

Email

suzuki.toyofumi@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

47

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

In preparation

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 05 Month 01 Day

Date of IRB

2017 Year 05 Month 01 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2018 Year 05 Month 31 Day

Date of closure to data entry

2018 Year 08 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 10 Month 25 Day

Last modified on

2019 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033956


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name